EAM
TNYA icon

Empery Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Empery Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Sell
3,863,115
-423,818
-10% -$322K 3.3% 9
2026
Q1 		$2.97M Sell
4,286,933
-1,127,168
-21% -$832K 3.58% 6
2025
Q4 		$3.85M Buy
+5,414,101
New +$7.36M 3.4% 7

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Empery Asset Management's TNYA Position: Q2 2026 in Review

Empery Asset Management reduced its Tenaya Therapeutics (TNYA) stake by 9.9% in Q2 2026, selling an estimated $322K and leaving 3,863,115 shares worth $2.86M. The position accounts for 3.3% of the portfolio, ranked #9.

Empery Asset Management first reported a position in TNYA in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.85M in Q4 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Empery Asset Management held 3,863,115 shares of Tenaya Therapeutics worth $2.86M as of Q2 2026.
  • Empery Asset Management sold 423,818 Tenaya Therapeutics shares in Q2 2026, an estimated $322K.
  • Tenaya Therapeutics made up 3.3% of Empery Asset Management's portfolio in Q2 2026, its #9 holding.
  • Empery Asset Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Empery Asset Management's Tenaya Therapeutics position peaked at $3.85M in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.